Characterization of Glycosylation Profiles of HIV-1 Transmitted/Founder Envelopes by Mass Spectrometry
- 15 August 2011
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 85 (16) , 8270-8284
- https://doi.org/10.1128/jvi.05053-11
Abstract
The analysis of HIV-1 envelope carbohydrates is critical to understanding their roles in HIV-1 transmission as well as in binding of envelope to HIV-1 antibodies. However, direct analysis of protein glycosylation by glycopeptide-based mass mapping approaches involves structural simplification of proteins with the use of a protease followed by an isolation and/or enrichment step before mass analysis. The successful completion of glycosylation analysis is still a major analytical challenge due to the complexity of samples, wide dynamic range of glycopeptide concentrations, and glycosylation heterogeneity. Here, we use a novel experimental workflow that includes an up-front complete or partial enzymatic deglycosylation step before trypsin digestion to characterize the glycosylation patterns and maximize the glycosylation coverage of two recombinant HIV-1 transmitted/founder envelope oligomers derived from clade B and C viruses isolated from acute infection and expressed in 293T cells. Our results show that both transmitted/founder Envs had similar degrees of glycosylation site occupancy as well as similar glycan profiles. Compared to 293T-derived recombinant Envs from viruses isolated from chronic HIV-1, transmitted/founder Envs displayed marked differences in their glycosylation site occupancies and in their amounts of complex glycans. Our analysis reveals that the glycosylation patterns of transmitted/founder Envs from two different clades (B and C) are more similar to each other than they are to the glycosylation patterns of chronic HIV-1 Envs derived from their own clades.Keywords
This publication has 73 references indexed in Scilit:
- Methods development for analysis of partially deglycosylated proteins and application to an HIV envelope protein vaccine candidateInternational Journal of Mass Spectrometry, 2011
- Expression-System-Dependent Modulation of HIV-1 Envelope Glycoprotein Antigenicity and ImmunogenicityJournal of Molecular Biology, 2010
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandNew England Journal of Medicine, 2009
- Glycomics and disease markersCurrent Opinion in Chemical Biology, 2009
- Determination of glycosylation sites and site-specific heterogeneity in glycoproteinsPublished by Elsevier ,2009
- Glycosylation Site-Specific Analysis of Clade C HIV-1 Envelope ProteinsJournal of Proteome Research, 2009
- Mass spectrometry in the analysis of N-linked and O-linked glycansCurrent Opinion in Structural Biology, 2009
- Mass Spectrometry and the Emerging Field of GlycomicsChemistry & Biology, 2008
- Glycosylation Site-Specific Analysis of HIV Envelope Proteins (JR-FL and CON-S) Reveals Major Differences in Glycosylation Site Occupancy, Glycoform Profiles, and Antigenic Epitopesʼ AccessibilityJournal of Proteome Research, 2008
- Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B virusesVirology, 2008